Genome-to-genome analysis highlights the effect of the human innate and adaptive immune systems on the hepatitis C virus

作者: M Azim Ansari , Vincent Pedergnana , Camilla LC Ip , Andrea Magri , Annette Von Delft

DOI: 10.1038/NG.3835

关键词:

摘要: Outcomes of hepatitis C virus (HCV) infection and treatment depend on viral host genetic factors. Here we use human genome-wide genotyping arrays new whole-genome HCV sequencing technologies to perform a systematic genome-to-genome study 542 individuals who were chronically infected with HCV, predominantly genotype 3. We show that both alleles genes encoding leukocyte antigen molecules components the interferon lambda innate immune system drive polymorphism. Additionally, IFNL4 genotypes determine load through mechanism dependent specific amino acid residue in NS5A protein. These findings highlight interplay between genome control.

参考文章(63)
Andrea Magri, Roisin Reilly, Nicolò Scalacci, Marco Radi, Michael Hunter, Manon Ripoll, Arvind H. Patel, Daniele Castagnolo, Rethinking the old antiviral drug moroxydine: Discovery of novel analogues as anti-hepatitis C virus (HCV) agents. Bioorganic & Medicinal Chemistry Letters. ,vol. 25, pp. 5372- 5376 ,(2015) , 10.1016/J.BMCL.2015.09.029
David Bonsall, M. Azim Ansari, Camilla Ip, Amy Trebes, Anthony Brown, Paul Klenerman, David Buck, Paolo Piazza, Eleanor Barnes, Rory Bowden, , ve-SEQ: Robust, unbiased enrichment for streamlined detection and whole-genome sequencing of HCV and other highly diverse pathogens. F1000Research. ,vol. 4, pp. 1062- 1062 ,(2015) , 10.12688/F1000RESEARCH.7111.1
J. Ampuero, M. Romero-Gómez, K. R. Reddy, Review article: HCV genotype 3 – the new treatment challenge Alimentary Pharmacology & Therapeutics. ,vol. 39, pp. 686- 698 ,(2014) , 10.1111/APT.12646
Khayriyyah Mohd Hanafiah, Justina Groeger, Abraham D. Flaxman, Steven T. Wiersma, Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. ,vol. 57, pp. 1333- 1342 ,(2013) , 10.1002/HEP.26141
Timothy L. Tellinghuisen, Katie L. Foss, Jason Treadaway, Regulation of hepatitis C virion production via phosphorylation of the NS5A protein. PLOS Pathogens. ,vol. 4, ,(2008) , 10.1371/JOURNAL.PPAT.1000032
Christoph Neumann-Haefelin, Cesar Oniangue-Ndza, Thomas Kuntzen, Julia Schmidt, Katja Nitschke, John Sidney, Célia Caillet-Saguy, Marco Binder, Nadine Kersting, Michael W. Kemper, Karen A. Power, Susan Ingber, Laura L. Reyor, Kelsey Hills-Evans, Arthur Y. Kim, Georg M. Lauer, Volker Lohmann, Alessandro Sette, Matthew R. Henn, Stéphane Bressanelli, Robert Thimme, Todd M. Allen, Human leukocyte antigen B27 selects for rare escape mutations that significantly impair hepatitis C virus replication and require compensatory mutations. Hepatology. ,vol. 54, pp. 1157- 1166 ,(2011) , 10.1002/HEP.24541
Pierre‐Yves Bochud, Stéphanie Bibert, Zoltán Kutalik, Etienne Patin, Julien Guergnon, Bertrand Nalpas, Nicolas Goossens, Lorenz Kuske, Beat Müllhaupt, Tillman Gerlach, Markus H Heim, Darius Moradpour, Andreas Cerny, Raffaele Malinverni, Stephan Regenass, Guenter Dollenmaier, Hans Hirsch, Gladys Martinetti, Meri Gorgiewski, Marc Bourlière, Thierry Poynard, Ioannis Theodorou, Laurent Abel, Stanislas Pol, Jean‐François Dufour, Francesco Negro, Swiss Hepatitis C Cohort Study Group the ANRS HC EP 26 Genoscan Study Group, None, IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes†‡§ Hepatology. ,vol. 55, pp. 384- 394 ,(2012) , 10.1002/HEP.24678
Philippe Halfon, Stephen Locarnini, Hepatitis C virus resistance to protease inhibitors Journal of Hepatology. ,vol. 55, pp. 192- 206 ,(2011) , 10.1016/J.JHEP.2011.01.011
Stanislas Pol, Anaïs Vallet-Pichard, Marion Corouge, Treatment of hepatitis C virus genotype 3-infection. Liver International. ,vol. 34, pp. 18- 23 ,(2014) , 10.1111/LIV.12405